[1] |
Roayaie S, Guarrera JV, Ye MQ, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes[J]. J Am Coll Surg, 1998, 187(4):365-372.
|
[2] |
Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2012, 379(9822):1245-1255.
|
[3] |
Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2009, 135(8): 1073-1080.
|
[4] |
Brychtova V, Zampachova V, Hrstka R, et al. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma[J]. Exp Mol Pathol, 2014, 96(3):375-381.
|
[5] |
Kim YK, Kim CS, Han YM, et al. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma[J]. Clin Radiol, 2010, 65(5):358-365.
|
[6] |
Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection[J]. Abdom Imaging, 2013, 38(6):1334-1350.
|
[7] |
Shah A, Tang A, Santillan C, et al. Cirrhotic liver: what's that nodule? the LI-RADS approach[J]. J Magn Reson Imaging, 2016, 43(2):281-294.
|
[8] |
Hanna RF, Aguirre DA, Kased N, et al. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features[J]. Radiographics, 2008, 28(3):747-769.
|
[9] |
Choi SY, Kim YK, Min JH, et al. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging[J]. Eur Radiol, 2018, 28(6):2549-2560.
|
[10] |
Park HJ, Kim YK, Park MJ, et al. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma[J]. Abdom Imaging, 2013, 38(4):793-801.
|
[11] |
Chong YS, Kim YK, Lee MW, et al. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI[J]. Clin Radiol, 2012, 67(8):766-773.
|
[12] |
Lee JD, Yun M, Lee JM, et al. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography[J]. Eur J Nucl Med Mol Imaging, 2004, 31(12):1621-1630.
|
[13] |
Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses[J]. J Nucl Med, 2003, 44(2):213-221.
|
[14] |
Kim YJ, Yun M, Lee WJ, et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma[J]. Eur J Nucl Med Mol Imaging, 2003, 30(11):1467-1472.
|
[15] |
Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48(4):441-446.
|
[16] |
Kirienko M, Cozzi L, Rossi A, et al. Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions[J]. Eur J Nucl Med Mol Imaging, 2018, 45(10):1649-1660.
|
[17] |
Nasu K, Kuroki Y, Tsukamoto T, et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade[J]. AJR Am J Roentgenol, 2009, 193(2):438-444.
|
[18] |
Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network[J]. Magn Reson Imaging, 2012, 30(9):1323-1341.
|
[19] |
Harrell Frank E., Jr. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis[M]. New York: Springer-Verlag, 2015.
|
[20] |
Zhao YJ, Chen WX, Wu DS, et al. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings[J]. Abdom Radiol, 2016, 41(5):978-989.
|
[21] |
Xue R, Li R, Guo H, et al. Variable intra-tumor genomic heterogeneity of multiple lesions in patients with hepatocellular carcinoma[J]. Gastroenterology, 2016, 150(4):998-1008.
|
[22] |
Chicklore S, Goh V, Siddique M, et al. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis[J]. Eur J Nucl Med Mol Imaging, 2013, 40(1):133-140.
|